Logo
T

Tango Therapeutics

127 employees

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cancer
drug discovery
Therapeutics
functional genomics
synthetic lethality
pharmaceutical research
Medical
Health Care

Date founded

2017

Funding rounds raised

Total raised

$186M

from 11 investors over 11 rounds

T

Tango Therapeutics raised $186M on August 11, 2021

Investors: Surveyor Capital, Logos Global Management, LP, Samsara BioCapital, Gilead Sciences, Foresite Capital, RA Capital Management, L.P. and Woodline Partners LP

T

Tango Therapeutics raised $50M on August 17, 2020

Investors: Gilead Sciences and Casdin Capital, LLC

T

Tango Therapeutics raised $60M on April 9, 2020

Investors: Casdin Capital, LLC

T

Tango Therapeutics raised $55M on March 30, 2017

Investors: Third Rock Ventures

FAQ